Inotiv, Inc. (NASDAQ:NOTV) CEO Robert Jr. Leasure Sells 73,617 Shares

Inotiv, Inc. (NASDAQ:NOTV) CEO Robert Jr. Leasure sold 73,617 shares of the stock in a transaction that occurred on Tuesday, February 18th. The shares were sold at an average price of $3.82, for a total transaction of $281,216.94. Following the completion of the transaction, the chief executive officer now owns 956,592 shares in the company, valued at $3,654,181.44. This represents a 7.15 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Robert Jr. Leasure also recently made the following trade(s):

• On Friday, January 31st, Robert Jr. Leasure sold 22,700 shares of Inotiv stock. The shares were sold at an average price of $4.15, for a total transaction of $94,205.00.

Inotiv Stock Performance

Shares of Inotiv stock opened at $4.25 on Friday. The firm has a market capitalization of $143.31 million, a P/E ratio of -0.92 and a beta of 3.58. Inotiv, Inc. has a 52 week low of $1.23 and a 52 week high of $11.42. The company has a quick ratio of 1.28, a current ratio of 1.57 and a debt-to-equity ratio of 2.31. The firm’s 50 day moving average is $4.36 and its two-hundred day moving average is $2.94.

Inotiv (NASDAQ:NOTV) last announced its earnings results on Wednesday, February 5th. The company reported ($0.42) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.32) by ($0.10). Inotiv had a negative return on equity of 15.41% and a negative net margin of 25.40%. Research analysts forecast that Inotiv, Inc. will post -0.79 EPS for the current fiscal year.

Hedge Funds Weigh In On Inotiv

A number of hedge funds have recently modified their holdings of the business. Two Sigma Advisers LP grew its position in shares of Inotiv by 31.6% during the fourth quarter. Two Sigma Advisers LP now owns 22,500 shares of the company’s stock worth $93,000 after acquiring an additional 5,400 shares during the last quarter. Dimensional Fund Advisors LP grew its position in shares of Inotiv by 24.5% during the fourth quarter. Dimensional Fund Advisors LP now owns 31,626 shares of the company’s stock worth $131,000 after acquiring an additional 6,216 shares during the last quarter. Northern Trust Corp grew its position in shares of Inotiv by 20.2% during the fourth quarter. Northern Trust Corp now owns 48,372 shares of the company’s stock worth $200,000 after acquiring an additional 8,134 shares during the last quarter. Bay Colony Advisory Group Inc d b a Bay Colony Advisors purchased a new position in Inotiv in the 4th quarter valued at $60,000. Finally, Geode Capital Management LLC grew its position in Inotiv by 7.7% in the 3rd quarter. Geode Capital Management LLC now owns 250,895 shares of the company’s stock valued at $427,000 after buying an additional 18,039 shares during the last quarter. 18.17% of the stock is currently owned by hedge funds and other institutional investors.

About Inotiv

Inotiv, Inc provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries. It operates through two segment: Discovery and Safety Assessment (DSA), and Research Models and Services (RMS). The DMS segment manufactured scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the Company's BASi product line.